Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 7, 2026; 32(25): 119071
Published online Jul 7, 2026. doi: 10.3748/wjg.119071
Published online Jul 7, 2026. doi: 10.3748/wjg.119071
Figure 3 Radiomics and pathomics nomograms and calibration curves.
A and B: Radiomics and pathomics nomograms for predicting Crohn’s disease mucosal healing status in the ileal and ileocolonic region; C and D: In the ileal and ileocolonic region, calibration curves of the combined models in the testing set. Alb: Albumin; FC: Fecal calprotectin.
- Citation: Zhang H, Liu HM, Pei JX, Hu J, Zhu C, Liu KC, Rong C, Zheng XM, Shen Y, Cai YP, Wu XW. Baseline multimodal clinical-radiomics-pathomics model predicts mucosal healing in Crohn’s disease after infliximab therapy. World J Gastroenterol 2026; 32(25): 119071
- URL: https://www.wjgnet.com/1007-9327/full/v32/i25/119071.htm
- DOI: https://dx.doi.org/10.3748/wjg.119071